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Alkylpyrazine compounds occur at varying levels in a variety of 
roasted food products as well as in several uncooked food products. 
Pyrazine compounds are utilized as drugs. Pyrazinamide is a drug 
used in large dosages (0.5 - 1.0 gm orally) to treat tuberculosis (1), 
Further, there exists a recent patent for the use of pyrazines as 
food flavor additives (2), It is conceivable that pyrazine compounds 
can be consumed in greater amounts than the levels encountered in 
natural foods. It would be advantageous to perform long studies on 
the possible effects of repeated subtoxic doses. Little information 
on the metabolism or toxicity of these compounds has been reported 
in the literature. 
Among food additives approved by the United States Food and 
Drug Administration on the bas·is of "generally-recognized-as-safe," 
(GRAS} substances (3) are several alkylpyrazines. 
It is important to be aware that the definition of toxicity is 
established at a given time; what is called a "safe" compound of 
yesterday, by newer standards and methods, may afterwards be shown 
as harmful. 
This thesis will report the multistep synthesis of a radioactive 
dialkylpyrazine, When purified 2,3- 14c-2,3-dimethylpyrazine was 
injected into a rat intraperitoneally, little or none of the 
1 
2 
radioactivity was eliminated as respired 14co2 , a small amount of the 
radioactivity was found in the feces, and 84 per cent of the label was 
located in the urine. In addition, this study verifies Koehler's 





The preparation of "amarone" was first described in 1844 by 
Laurent (5) and was recently reviewed by :Krems and Spoerri (6). Pratt 
noted that "amarone" was identified as tetraphenylpyrazine (I) (7). 
Krems and Spoerri, in their review on the chemistry of pyrazines, 
listed several methods of preparation of pyrazines: autocondensation 
of a-primary aminocarbonyls, autocondensation of a-hydroxyimines, 
condensation of a, S-diamines with a, S-dicarbonyls, the action of 
ammonia (or its salts) on polyhydroxy compounds, the action of hydra-
zine or hydroxylamine on dihydroxymorpholine, the dehydrogenation of 
piperazines and other lesser known methods (6). Oxidation of pipera-
zines over a suitable catalyst is used commercially to form pyrazines. 
According to Pratt an indirect route of synthesis of pyrazine is 
decarboxylation o'f pyrazinecarboxylic a~id1s. (7 ). Until recentfy the most 
3 
efficient method for pyrazine synthesis was that of "1olff andMarburg 
from the acetal of iminodiacetaldehyde (8). Treatment with hydro-
chloric acid forms 2,6-dihydroxymorpholine which reacts with hydro-
xylamine to yield pyrazine. The fact that the starting material is 
difficult to obtain is the principle disadvantage. Examples of auto-
condensation of a-primary aminocarbonyls include reduction of amino 
acids, oxidation of amino alcohols, replacement of the hydroxyl in a 
hydroxycarbonyl with an amino acid group, replacement of one carbonyl 
group in a dicarbonyl compound with ~ti. amino group and the action of ,, 
/ 
acetic anyhydride and pyridine on1 amino acids (6). 
This author used direct formation of pyrazine by condensation of 
an a, S-diamine with an a, S-dicarbonyl. Synthesis was begun with 
ethylmagnesium bromide formation suggested by Skatteb.Sl, et al., in 
ether instead of tetrahydrofuran (9, 10). Gilman and Nelson reported 
that ethylmagn~~ium bromide will react with anµydrous cadmium chloride 
to form diethyl cadmium (ll), Cason contributed the next step of 
reacting diethyl cadmium to an acid chloride such as acetyl chloride 
(12). The ketone produced is 2-butanone. An oxime can be produced 
from 2-butanone by a method des·cribed by Hartung and Crossley (13). 
Hydrolysis of the oxime with dilute acid resulted in the formation of 
diacetyl (10). Flament and Stoll showed how diacetyl can conderise 
with ethylenediamine producing 2,3-dimethyl-5,6-dihydropyrazine (14). 
Two, three-dimethyl-5,6-dihydropyrazine can be catalytically 
dehydrogenated to 2,3-dimethylpyrazine at high temperatures as 
reported by Ishiguro, et al. (15). 
Kikk~ji and Neuberg reported that rabbit$ fed doses of amino-
acetaldehyde hydrochloride converted the compound to pyrazine which 
4 
can be isolated from the urin~. (16), Other pyrazine-like compounds 
have been isolated from plants, indicating a biosynthetic pathway. 
Kosuge, et al, proposed the biosynthesis of tetramethylpyrazine from 
ammonia and acetoin (17), 
In 1962, Japanese workers reporte4 teq~a:methylpyrazine to be a 
flavor component of ~tto, a fermented soybean product consumed in 
considerable quantities by the Japanese (18). More recently Kosuge, 
et al. detected tetramethylpyrazine in many Japanese foodstuffs, Miso 
and soy sauce in particular, suggesting that alkylpyrazines may play 
., ....... ,,.. ... ~~ 
an important role as flavor components of these foodstuffs (17). 
Tetramethylpyrazine was isolated from Bacillus subtilis and Bacillus 
natto, which ferments soybean to pro<iuce "natto" (17). Another 
pyrazine, 2-methoxy-3-isobutylpyrazine, is responsible for the aroma 
of the California green bell pepper and is the major component of that 
5· 
pepper's oil when obtained by steam-distillation (19). Bramwell, et al. 
found 2-methoxy-3-sec-butylpyrazine and other pyrazines in Galbanum 
oil (20). Murray, et al. observed 3-is!Jpropyl-2-methoxyp)1razine, 
3-s-butyl-2-methoxypyrazine and 2-methoxy-3...iisobutylpyrazine in green 
peas (21). Biosynthesis from a-amino acids is suggested. White and 
Hill found asper~illic acid (II) to be of relatively high toxicity. 
It is a product of a strain of Aspergillus flavus grown on a certain 
liquid medium (22). The above pyrazines found in non-roasted foods 
indicates biosynthesis of pyrazines in plants and microorganisms. 
The first report of pyrazine in foods was that of Standinger and 
Reichstein in which pyrazines were isolated from coffee (23). Giantur-
,to ::confirmed their results for coffee and, in addition, discovered 
the presence of several dimethylpyrazines (24, 23). Mason, et al, 
6 
recently showed that a major portion of the volatile components of 
roasted peanuts are alkylated pyrazines, and evidence has accumulated 
to indicate the presence of compounds substituted with alkyl groups 
containing up to five carbons (25). Deck and Chang reported th~ isola-
tion of dimethylpyrazine from potato chips in addition to several 
other alky.lated derivatives (26). Buttery, et al. recently confirmed 
that many pyrazines contributing to odor are present in the basic 
fraction of the steam volatile oil from potato chips (27, 26). Diet-
rich, et al. reported 2,6-dimethyl- and tetramethylpyrazine in cocoa 
and Rizzi has found a number of alkylated pyrazines in cocoa butter 
including 2,3-dimethylpyrazine (28, 29). There is a French patent to 
add methylpyrazines (1-200 ppm) to enhance flavor of chocolate and 
cocoa preparations (30). Neurath and Duengerhave isolated weakly 
basic heteroaromatic compounds from tobacco smoke (31), Duenger 
patented a method for improving and enriching tobacco smoke flavor by 
adding mono-, di-, tri-; or tetra-substituted derivatives of pyrazine 
(0.005 - 5.0% by wt.) to the tobacco (32). Seifert, et al. reported 
that since 2-isobutyl-3-methoxypyraz.ine has an extremely potent aroma 
and is already in commercial use as a flavoring material, compounds 
with related structures are being studied as possible flavoring 
material for nutritious, high protein foods which may have flavor 
deficiencies (33). Sapers, et al. noted that the toast~d off-flavor 
of puffed dehydrated potato is due, in part, to the presence of 
several alkylpyrazines (34). 
Gas chromatography-mass spectrometer analysis of roasted meat 
flavor prepared by pyrolysis of water-soluble r,bmponents of fresh beef 
has yielded 17 alkylpyrazines to Flament and Ohlaff (35). Watanabe 
7 
and Sato obtained at least nine alkyl-substituted pyrazines from the 
basic fraction of the total volatiles of shallow fried beef and pro-
posed a reaction between sugars and amino acids to produce a specific 
flavor in beef (36). Koehler, et al. demonstrated the production of 
alkylated pyrazines in model systems consisting of mixtures of amino 
acids and sugars heated in diethyleneglycol (37). The fact that 
pyrazines are produced when reducing sugars and a nitrogen source 
are heated together is not new, but these workers have succeeded in 
quantitatively reproducing the pyrazines found in roasted peanuts by 
heating, in the model systems, a mixture of certain amino acids and 
sugars found in raw peanuts. 
II 
Davidson and Wiggans reported that during the course of studies on 
high temperature annnoniation of molasses, steam distillable hetero-
cyclic base fractions appeared to contain both pyridin~ and pyrazine 
bases (38). The major constituent of a non-steam volatile fraction 
was 4(5)-methylimidazole, but the steam volatile fraction contained 
compounds similar to 2,5- and 2,6-dimethylpyrazines, Further work by 
Wiggans on annnoniated molasses revealed the production of five 
8 
pyrazine components (39). 
In more recent studies of by-products formed in the annnoniation of 
glucose, Nishie, et al. showed that pyrazine, several methylpyrazines, 
hydroxypyrazines and related compounds were produced (40). Mono- and 
dimethylpyrazines exhibit weak central nervous system depressant activ-
ity (hypnotic and anticonvulsant). Two, three-dimethylpyrazine was the 
most potent in this regard, producing approximately 1/13 the hypnotic 
activity of phenobarbital sodium. Pyrazines with either OH, CH20H or 
-(CH20H) 3-cH20H substituents were.relatively nontoxic (40). Pyrazine 
derivatives because of their selectivity for bacterial cells hold 
possible .value in antibacteria chemotherapy. Babek and Block prepared 
various pyrazine analogs of pyrimidines because of the marked anti~ 
tumor activity which derives from the structural modification of the 
heterocycle of the natural pyrimidine nucleosides (41). Among these, 
the uracil analog 1,2-dihydro-2-oxopyrazine 4-oxide, a compound which 
has been isolated as the antibiotic emimycin, was synthesized by an 
improved method involving the oxidation of benzoyloxypyrazine (41). 
Established metabolic pathways of related compounds may serve 
as a guide in studying metabolism of pyrazines. Oxidative ring cleav-
age may yield urea, co2 and water, Reductive cleavage would result in 
primary and secondary amines that would most likely be conjugated 
when excreted in the urine. For example, the drug sulfanilamide is 
excreted as the N-acetyl derivative. Formation of N-oxides or N-
methylpyrazines may represent major metabolites. N-methylation as a 
d.etoxication process is limited in the body, but pyridine derivatives 
are excreted as N-methyl conjugates. Oxidation and conjugation with 
glucuronide is another possible route of metabolism. Also pyrazines 
9 
may be excreted unchanged. The tranquilizer chlorpromazine is hydra-
xylated and excreted as a glucuronide (42). Koehler found that a small 
percentage of an injected dose of 2,5-dimethylpyrazine was not meta-
bolized (4). 
In the sulfonamide drug sulfapyrazine, the pyrazine ring is stable 
and the drug is excreted by rabbits mainly as the acetyl derivative, 
there being little, if any, hydroxylation of either ring (43). 
Stolte reported that fructosazine was oxidized to 2-methylol-5-
pyrazinoic acid and excreted in the urine (44). 
Pyrazinoic acid (IV) is rapidly absorbed from the alimentary tract 
and remains unchanged by the kidneys; one research group reports that 
one-fourth of an oral dose of 1 to 3 grams appears in the urine within 
two hours (45). Some work with pyrazinamides (III) is reported and 
hydrolysis of the amide was observed in elimination products, 





MATERIALS AND METHODS 
Synthetic Reagents 
Acetyl Chloride - Acetyl-l- 14c-Chloride was purchased from 
Tracerlab Radiochemical, Waltham, Massachusetts. Specific activity 
was l.SmCi/mM and the volume was 0.0475 ml. 
Magnesium, Cadmium Chloride, Concentrated Sulfuric~~ 
Sodium Nitrite - Purified magnesium turnings, cadmium chloride, con-
centrated sulfuric acid and sodium nitrite were purchased from 
J. T. Baker Chemical Company, Phillipsburg, New Jersey. 
Ethyl Bromide - Ethyl bromide was a product of Eastman Kodak 
Company, Rochester, New York 
Ether~ Ethylene Diamine - Anµydrous ether and anhydrous 
ethylene diamine were obtained from Fisher Scientific Company, Fair 
Lawn, New Jersey. 
Concentrated. J:!ydrochloric ~ - Concentrated. hydrochloric acid 
was a product of Mallinckrodt Chemical Works, St. Louis, Miss?uri. 
General Reagents 
Scintillation Solvent - Scintillation solvent was prepared accord-
ing to Bray (47), Fifteen milliliters were used when counting samples, 
..£Q2 Absorber - One normal NaOH was used to absorb co2 . The air 
was drawn through this solution via scintered glass bubblers submerged 
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in a series of four 3.Sx20 cm test tubes containing 70 ml, 60 ml, 
50 ml, and 40 ml 1 N NaOH. Each day this volume was adjusted to 
250 ml. 
Synthesis of 2,3- 14c-2,3-Dimethylpyrazine 
The synthetic scheme outlined in Figure 1 shows the major steps 
of the synthesis. Two complete series of these reactions were con-
ducted with unlabeled reactants to pretest the synthetic scheme. 
Grignard Synthesis 
11 
A one liter three-neck round-bottom flask was fitted with a 
mechanical stirrer, reflux condenser and an equal-pressure dropping 
funnel. The system was flamed out and dry nitrogen was passed through 
the system where 0,5 mole of ethylmagnesium bromide was prepared by 
slow addition of 0.5 mole of ethyl bromide in 375 ml ether to 0.5 mole 
of magnesium turnings while stirring. 
Diethyl Cadmium 
Diethylcadmium was formea by slow addition of 0.25 mole anhydrous 
cadmium chloride to the ethylmagnesium bromide. The flask was cooled 
with an ice bath during addition of cadmium chloride, After addition 
of the cadmium chloride heat was applied, with a heating mantel, to 
reflux the cadmium reagent for six to eight hours. 
Formation of 2- 14c-2-Butanone 
One mCi (0.0475 ml) acetyl-l- 14c-chloride was diluted with 5 ml 
of reagent grade acetyl chloride. This mixture was added slowly to the 
Figure 1. Synthesis Scheme of 2,3- 14c-2,3-Dimethylpyrazine 
From Acetyl-1- 14c-Chloride 
~(c~-C*Cd CH3 CH2-N0i 
0 ... 
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diethyl cadmium. Additional acetyl chloride was added to equal 
0.5 mole then the mixture was refluxed for three hours. Ice 
water, then 5 per cent H2so4 was used to dissolve the semisolid 
mass into two phases. To the upper, ether layer, 50 ml of 5 
per cent Na2co3 was added and then 50 ml of saturated NaCl. Both 
the Na2co3 and NaCl were discarded after shaking. Two-butanone 
was isolated and partially purified from the solution by fraction-
al distillation. The boiling point of 2-butanone is 79.6°c at 
1 atm. pressure. The two-step addition of acetyl chloride per-
mitted the maximum utilization of 14c label. 
Formation of Oxime. 
14 
Ethyl nitrite (formed from dropping a solution of 6.2 ml H2so4 , 
6.6 ml 95 per cent ethanol and H20 into a solution of 16.1 g NaN02 , 
6.6 ml 95 per cent ethanol and H20) was bubbled through the 20.0 ml of 
2-butanone with a small .amount of concentrated HCl to form 2,3-butane-
dione monooxime. This was salted out as a white flaky crystalline 
precipitate and collected on a Buchner funnel. 
Diacetyl Production 
The 16 .8 g of monooxime was hydroly·sed by s_lowly addiqg 
23.4 ml of cooled concen~rated H2so4 diluted to 67 ml with 
H2o. A solution of 27.5 g NaN02 dissolved in 67 ml H2o was 
also added to the solution. This was allowed to stand for 
three days to insure complete hydrolysis producing diacetyl. 
The 3.82 ml diacetyl from the synthesis was mixed with 25.45 
ml reagent diacetyl to equal 0.33 mole, 
Condensation with Ethylene Diamine 
To 0.33 mole ethylene diamine in 100 ml ether the 0.33 mole 
diacetyl also in 100 ml ether was added. The condensation reaction 
produced 2,3-dimethyl-5,6-dihydropyrazine which was collected under 
vacuum distillation at 53°-54°C, 12 mm Hg, The undried amount was 
12.3 ml. A 1.0 ml sample was removed for other experiments. 
Formation of 2,3-Dimethylpyrazine 
15 
The remaining 11.3 ml 2,3-dimethyl~5,6=dihydropyrazine was slowly 
dropped through a catalytic column of 10 per cent copper chromite on 
8-14 mesh F-1 alumina at 300°c. Recovery of 9.3 ml of 2,3-dimethyl-
pyrazine was made. Anhydrous Na2so4 was added to absorb any water in 
the solution leaving 8.0 ml pyrazine. 
Purification of 2,3-14c-2,3-Dimethylpyrazine 
A Varian Aerograph preparatory gas chromatograph, model 711, 
equipped with a Sargent recorder was used to purify the 2,3- 14c-2,3-
dimethylpyrazine. The column was 3/8 inch by 16 feet containing 
15% ~arbowax on Gas Chrom Q. Column conditions are described in the 
legend of Figure 2. The 2,3-dimethylpyrazine was trapped in dichloro'-
metharte cooled with dry ice. 
Administration of 2,3- 14c-2,3-Dimethylpyrazine 
A normal saline solution, 0.75 to.0.94ml of 2,3- 14c-2,3.;dimethyl-
pyrazine, was injected intraperitoneally into a 100 - 200 g white 
female laboratory rat, approximately 350,000 dpm being administered 
to each animal. 
Figure 2. Preparatory Gas Chromatogr!fhic Tracing From Injec-
tion of Synthesized 2,3- C-2,3-Dimethylpyrazine. 
The operational parameters were: glass column of 
3/8" x 16'; 15% Carbowax on Gas Chrom Q; column 
temperature, 130°C; detector and injector temper-
ature, 250°C; and N2 flow rate of 55 ml/min. A 
flame ionization detector was used. Instrument 





The metabolism chamber was crafted from six-inch glass tubing 
in the Oklahoma State University glass shop. It was a sealed 
system in which air was drawn through co2-absorbing traps, and 
urine and feces were collected separately. Food and water were 
provided ad libitum to the rat. Food was Rockland Complete Mouse/ 
Rat Diet, the same diet that the animals had before the experiment. 
Figure 3 shows schematic representation of the metabolism chamber. 
Collection of urine, feces, and respired gases was made for 
each rat every 24 hours for a duration of six days. 
Column Chromatography 
Three resins were selected for ion-exchange chromato-
graphy: Dowex 1 x 2, chloride form, for the separation of 
purines and pyrimidines; Dowex 1 x 2, formate form, for 
the separation of nucleotides; and Amberlite CG-120, ammonium 
form, for the separation of nucl~~sides. Since the metabol-
ites of pyrazines possibly include compounds structurally 
similar to free bases or base-sugars, these columns were 
utilized. (48). 
The solvent schedul.e followed an increasing concentration 
of formic acid up to 4 M with increasing ammonium formate 
concentration to 0,2 M. The usual procedure involved placing 300 ml 
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of deionized water in the mixing chamber with the addition of 0.5 liter 
of 2 M formic acid, 0.5 liter of 4 M formic acid, and, finally, 0.5 
liter 4 M formic acid with 0.2 M ammonium formate. Column sizes are 
described on the legend of each figure. 
Figure 3. Metabolism Chamber Diagram. Air circulation by 
water aspiration. Twenty-four hour collection 
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Structural similarities of the pyrazines to purines and pyrimi-
dines was noted, and a spectrophotometric assay (A260) was utilized 
for urinary metabolites separated by ion~exchange chromatography. 
Absorbance of each fraction was determined with a Beckman DB spectro-
photometer. 
Liquid Scintillation Spectrometry 
The total radioactivity of urine samples was calculated from 
radioactive levels found in fractions from ion-exchange columns 
whereby an aUquot was added to 15 ml Bray's solution. Corrections 
applied to the raw counts per minute data include subtraction of 
blank; correction for instrument efficiency; quench:.corr~ct'ion;· . .and 
finaHy;._ dilution factor. 
Ionization Chamber Assay of 14co2 
The C02 respired by the rat was trapped in 1 N NaOH. The C02 
21 
of a 2 ml al!Lquot from a total volume of 250 ml was released with acid 
and introduced into an ion chamber. The radioactivity was measured 
with a Cary 31 Vibrating Reed E.lectrometer. 
\ .. Mass .. Spectral.Analy.sis. 
Two radioactive peaks were purified and dried by .lypp."!;l:ylizatio.n 
and a portion introduced by direct probe into the prototype LKB-9000 
Gas Chromatograph-Mass Spectrometer. Purification of the radioactive 
pyrazine metabolite followed the procedure of Pontis which involves 
adsorption onto activated carbon (Norit A) (49), Background spectra. 
were taken and used for correction. These mass spectral patterns 
were examined for pyrazine metabolite structural elucidation, 
22 
CHAPTER·IV 
RESULTS AND DISCUSSION 
Synthetic Yield 
The radioactive yield of the synthetic 2,3-14c-2,3-dimethyl-
pyrazine from acetyl-l- 14c-chloride is shown in Table I. This 
compound was judged to have the same odor as a commercial reference 
2,3-dimethylpyrazine. The retention times of the unpurified synthetic 
2,3- 14c-2,3-dimethylpyrazine, Figure 4, and the comrnercial reference, 
Figure 5, are similar. After purification, minor impurities were 
removed as outlined.below. The radioactivity of the minor impurities 
was not determined. The preparative purification step was necessary 
in order for the material to be used in metabolic study. The unpuri-
fied synthetic compound gave an overall yield of 2.6 per cent or 
26 µCi. A portion of this material was purified for the metabolic 
study. Specific activity of the purified 2,3- 14c-2,3-dimethylpyrazine 
was 230 mµCi/mM. 
Purification Yield 
The gas chromatographic tracing of synthetic 2,3- 14c-2,3-dimethyl-
pyrazine before purification is shown in Figure 4. From Figure 4 the 
synthesized mixture was estimated to be 71 per cent pure and of 
approximately the same purity as the product obtained from Chemicals 
Procurement Laboratories, Figure 5. Figure 6 shows the gas 
23 
TABLE I 
SYNTHETIC YIELD OF 2,3-14e-2,3-DIMETHYLPYRAZINE 
Compound 





2,3-Dimethylpyrazine 26 µc 








Figure 4. Gas-Liquid Chromatogram of Synthetic 
2,3-14c-2,3-Dimethylpyrazine. 
Column - 20' x 1/4", I.D. 
Column Packing - 15%.Carbowax on Gas Chrom Q 
Column Temperature - 130°c 
Injection Port Temperature-- 2S0°C 
Detector Temperature· - 250°c 
Carrier Gas - Nitroge~ 
Detector - Flame Ionization Detector 
Hydrogen Pressure·- 15 p.s.i, 
Air Pressure - 40 p.s.i. 
Nitrogen Pressure-- 40 p.s.i. 




Figure 5. Gas-Lig~id Chromatogram of Commercial Reference 
2, 3· Difnethylpyr.azine; · 
Column - 20 1 x 1/ 4", I.D. 
Column Packing - 15% Carbowax on Gas Chrom Q 
Column Temperature - 130°c 
Injection Port Temperature - 250°c 
Detector Temperature - 250°c 
Carrier Gas - Nitrogen 
Detector - Flame Ionization Detector 
Rydrogen Pressure - 15 p.s.i. 
Air Pressure - 40 p.s.i. 
Nitrogen Pressure - 40 p.s.i. 





Figure 6. Gas~~iguid Chromatogram of Synthetic, Purified 
. 2,3-I4C-2·,3~.Dimethylpyraziue. 
Column - 20' x 1/ 4", I.D. 
Column Packing - 15% Carbowax on Gas Chrom Q 
Column Temperature - 130°c 
Injection Port Temperature - 250°c 
Detector Temperature - 250°c 
Carrier Gas - Nitrogen 
Detector - Flame Ionization Detector 
Hydrogen Pressure - 15 p.s.i. 
Air Pressure - 40 p.s.i. 
Nitrogen Pressure - 40 p.s.i. 






chromatographic tracing of 2,3- 14c-2,3-dimethylpyrazine collected by 
preparative gas-liquid chromatography from the mixture. Minor impuri-
ties seen on the synthetic 2,3-14c-2,3-dimethylpyrazine gas chroma-
tographic tracing were apparently removed by this purification step. 
The mass spectra of both unpurified synthesized 2,3- 14c-2,3-dimethyl-
pyrazine and connnercial reference 2,3- 14c-2,3-dimethylpyrazine are 
shown in Figure 7. The method of introduction into the mass spectro-
meter was via the molecular separator which reduces the introduction of 
some impurities.· The spectra are observed to be essentially the same. 
Administration of 2,3~ 14c-2,3-Di~ethy1pyrazine 
Two control and four treatment rats were held individually for a 
period of six days each in the metabolic chamber. The four treatment 
rats received approximately 350,000 dpm of the purified labeled 
2,3-dimethylpyrazine in normal saline solution. An anesthetic ef~ect 
was observed for each treatment rat upon injection of 2,3~ 14c-2,3-
dimethylpyrazine. This effect lasted for two to three hours following 
injection and could have been due to a small amount of dichloromethane 
having remained in the 2,3- 14C-2,3-dimethylpyrazine solution. 
Daily Excretion 
With Rat 1 and Rat 2 no detectible 14co2 was observed in respira-
tion gases; therefore, co2 collection procedure was discontinued for 
Rats 3 and 4. The Cary ·31 Vibrating Reed Electrometer was used to 
14 assay co2 , and only a background reading was obtained from 0.8 per 
cent of the total collection for Rats 1 and 2 duringeach of the first 
four days. After the first two experiments the co2 collection 
procedure was discontinued. 
Figure 7. Mass Spectra of Synthesized 2,3- 14c-2,3- Dimethyl-
pyrazine and Conunercial Reference 2,3-Dimethyl-
pyrazine. 
A. Synthesized 2,3- 14c-2,3-Dimethylpyrazine 
Before Purification 





































































Less than ten per cent of the :, radioactivity was found in the 
feces by extraction with dichloromethane. Due to the difficulty of 
completely separating the feces from the urine it would appear that 
some of the radioactivity found in the feces was from the urine, thus 
this procedure was discontinued for Rats 3 and 4. Approximately 84 
per cent of the administered radioactivity was excreted in the urine. 
Table II shows the four rats' daily radioactive urinary excretion. 
Koehler reported that 0.43 per cent of a dose of 2,S~dimethyl-
pyrazine was respired through the lungs in the first 24 hours and 
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that none was eliminated unchanged in the feces in the first three days. 
Koehler also found 2 .5 per cent and 1.1 per cent of 2 ,5-dimethylpyra-
zine eliminated unchanged in the urine in the first 24 hours after 
intraperitoneal administration (4).' 
Most of the administered pyrazine was eliminated via the urine 
within the first 24 hours. 
Characterizatic,n of Urinary Metabolites 
Characterization of ur,inary metabolites of 2 ,3 .. 14c-2 ,3-dimethyl-
pyrazine was attempted. 
Some of the radioactivity in the urine of the rats of this experi-
ment was excreted as unchanged 2,3~dimethylpyrazine. This was shown 
by the mass spectra of Feak I, Figure 11, separated by ion-exchange 
chromatography (Dowex 1 x 2, formate form column). In the mass spectra, 
Figure 8, a large m/e 67 and 108 indicates unchanged 2,3-dimethyl-
pyrazine excreted in the urine. Figure 9 shows the mass spectra of the 
compound in the second major radioactive peak, No conclusions can be 
made at this time as to structure. Further study is indicated. 
TABLE II 
URINARY EXCRETION OF RADIOACTIVITY BY RATS 
ADMINISTERED l4c-DIMETHYLPYRAZINE 
Per Cent Dose 
Day Rat·l Rat 2 Rat 3 Rat.4 
1 77 .7 86.6 6;2.7 87.6 
2 3.8 1.4 0.8 2.1 
3 1.3 0.1 0.4 o.o 
4 1.8 0.2 o.o 0.1 
5 4.0 0.1 0.1 o.o 
6 1.6 0.1 0.0 0.0 
Total 90.2 88.5 84.0 89.8 
Rat 1 received 330,000 dpm. 
Rats 2, 3, and 4 received 3S2,000 dpm. 
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Figure 8. Mass Spectra of the Purified Compound From Peak I 












































Figure 9. Mass Spectra of the Purified Compound From Peak II 
















































Three types of ion-exchange columns were used in an attempt to 
separate urinary metabolites:. Dowex 1 x 2, chloride form; Dowex 1 x 2, 
for~ate form; and Amberlite. CG-120, ammonium form, The absorbance 
readings and liquid scintillation assays versus fraction number are 
shown in Figures 10, 11, and 12. The powex 1 x 2 formate form co:1.umns 
produced a cleaner separation of metabolites, so a control rat urine 
sample was also chromatographed using this type of column with results 
shown in Figures 11, 13, and 14. The first separation (Figure 11) 
indicates two major radioactive metabolites which absorb at A260. As 
stated earlier, Peak I contained unchanged pyrazine; it was not pos-
sible to structurally characterize Peak II. Figure 14 shows a better 
separation of urinary metabolites, Time did not permit characteriza-
tion of the three to four radioactive metabolites shown in Figure 14. 
A minor change in solvent schedule gave a better separation, as shown 
in Figure 14. It is of interest to note that there are A260 absorb-
ing compounds present in the control rat's urine occurring at different 
elution volumes. There was a difference in storage conditions of the 
rat urine samples chromatographed on Dowex 1 x 2 formate forms as 
shown in Figures 11 and 14. The sample shown in Figure 11 was stored 
in a cold room at s0 c for two to three weeks while the sample shown 
0 in Figure 14 was stored at -20 C for three to four weeks. 
Since 2,3-dimethylpyrazine can be detoxified by hydroxylation of 
the ring or methyl groups, this would be a possible route of metabolism. 
The mass spectrometry data of Figures 8 and 9. show no significant m/e 
124, thus ruling out any mon:o-N-oxydimethylpyrazine, monohydroxydi-
methylpyrazine or monomethylolmonomethylpyrazine, This, however, does 
not limit the possibility that these three compounds could be metabolic 
Figure 10. Separation of Rat Urine Pyrazine Metabolites on a 
Dowex 1 x 2 Chloride Form Column. Column Size 
Was 1 x 50 cm. Particle Size Was 100~200 Mesh. 
Sample Size Was 1/5 of a 6-Day Collection. 
Solvent Schedule Was: 300 ml HzO; 1000 ml 0.2M 
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Figure 11. Separation of Rat Urine Pyrazine Metabolites on a 
Dowex 1 x 2, Formate Form Column. Column Size Was 
1.8 x 35 cm. Particle Size Was 100-200 Mesh. Sam-
ple Size Was 1/5 of 6-Day Collection. Solvent 
Schedule Was: 300 ml H20; 500 ml 2N HCOOH; 500 ml 
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Figure 12. Separation of Rat Urine Pyrazine Metabolites on an 
Amberlite CG-120, Ammonium Form Column. Column 
Size Was 2.2 x 35 cm. Particle Size Was 100-200 
Mesh. Sample Size Was 1/5 of 6=Day Collection. 
Solvent Schedule Was: 500 ml H20; 500 ml 0.2M 
NH4CH02; and 500 ml 0.4 NH4CH02, 0.04 HCOOH. 
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Figure 13. Separation of Control Rat Urine Sample on Dowex 1 x 2~ 
Formate Form Column. Column Size Was 1.8 x 60 cm. 
Particle Size Was 100-200 Mesh. Sample Size Was 
2/5 of a 3-Day Collection. Solvent Schedule Was: 
500 ml HzO; 500 ml 2N HCOOH; 500 ml 4N HCOOH; and 
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Figure 14. Separation of Rat Urine Pyrazine Metabolites on a 
Dowex 1 x 2, Formate Form.Column. Column Size 
Was 1.8 x 60 cm. Particle Size Was 100-200 Mesh. 
Sample Size Was 1/10 of Day One. Solvent 
Schedule Was: 500 ml H20; 500 ml 2N HCOOH; 
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intermediates. The di-N-oxide, dimethylol, dihydroxydimethylpyrazine 
or a combination of any two of these three different functional groups 
holds potential as a final metabolite of 2,3-dimethylpyrazine, since 
there is an m/e 140 shown in Figure 8. There is no mass spectra 
evidence from the two metabolite peaks to support a glucuronide con-
jugate of 2,3-dimethylpyrazine. With a glucuronide m./e 193, 167, and 
124 would be expected, but these are not prominent in either Figure 8 
or Figure 9. 
Williams reported that in the drug sulfapyrazine the pyrazine 
ring is stable and that the drug is excreted by rabbits in the acetyl-
ated form (43). Little, if any, hydroxylation occurs, 
An idea of the metabolism of dimethylpyrazine can be derived from 
the literature and facts presented. Some remains unchanged. Oxidative 
and reductive ring cleavage is unlikely because of the stability of the 
pyrazine ring and little or no 14co2 was found in the respired breath 
of the rats in th:i,s experiment. N-methylpyrazines, hydroxypyrazines 
and the glucuronides are poss:i,bilities, but there is no mass spectral 
evidence for this route of metabolism in this research report. Also, 
other conjugates, such as acetyl derivatives, are possible, There is 
some mass spectra evidence to support the possibility that the di-N-
oxide, dimethylolpy~azine or a combination of the two functional groups 
is produced. 
The metabolic route of 2,3-dimethylpyrazine from the point of 
injection to excretion in the urine proceeds from the peritoneal 
cavity across the mesentary to the abundant capillary supply of the 
intestinal wall by diffusion, then to the liver by the bJ.oodstream, 
where it is metabolised. 
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The 2,3-dimethylpyrazine may be shuttled directly to the kidneys, 
metabolized there, and then excreted. Future experiments should in .. :: 
elude the incubation of pyrazines with liver and kidney homogenate 
or microsomal fractions. Time-location studies of pyrazine in various 
organs would also indicate specifically where metabolism.occurs. 
CHAPTER V 
SUMMARY 
The chemical synthesis and purification of 2,3- 14c-2,3-dimethyl-
pyrazine has been completed. The metabolism of this compound in the 
rat shows that about 80 per cent of the administered dose is excreted 
in the urine within 24 hours. Biochemical alteration of the compound 
does occur, and some unchanged pyrazine appears in the urine. Less 
than 1 per cent of the administered dose is respired as 14co in any 
2 
24 hour period. 
Ion exchange techniques developed for the separation of nucleo-
tide type compounds have been successfully applied to pyrazine urinary 
metabolites. The metabolites isolated from powex 1 x 2, formate form, 
column have been examined by low resolution mass spectrometry and 
no reliable structural identifications have been made. Further work is 
needed to define the major pyrazine metabolites. 
Application of the techniq1,1es developed in this study might be 
made in metabolic studies utilizing liver homogenates or subcellular 
fraction. It is expected that structural identification will require 
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